* Ultralife Corp ULBI.OQ reported a quarterly adjusted
loss of 1
cent per share for the quarter ended in March. The lone
analyst forecast for the quarter was for a loss of 10 cents per
share.
* Revenue rose 5.1% to $31.92 million from a year ago;
analysts
expected $27.00 million.
* Ultralife Corp's reported EPS for the quarter was a loss
of 2
cents.
* The mean earnings estimate of analysts had fallen by
about 433.3% in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Ultralife Corp shares had risen by 0.9% this quarter and
gained 5.1% so far this year.
* The company reported a quarterly loss of $346 thousand.
* Wall Street's median 12-month price target for Ultralife
Corp is
$12.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
April 27 at 01:33 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2023 -0.10 -0.01 Beat
Sep. 30 2022 0.04 -0.01 Missed
Jun. 30 2022 0.01 0.03 Beat